News | Page 16 | Weill Department of Medicine

Suzanne Ross, Associate Director of Communications, Retiring After 34 Years of Dedication and Service

Suzanne Ross, Associate Director of Communications, Dept. of Medicine

Suzanne RossCongratulations to Suzanne Ross who will be retiring as our Associate Director of Communications in the Department.Suzanne has been with the Medical College for 34 years and has spent 20 of those years in the Department. She was responsible for the production of our annual reports and wrote all the stories for the department newsletters and website. She was also a resource to the Divisions for various marketing and publications initiatives. Prior to joining Medicine, Suzanne was... Read More

Drs. Kaner and Glesby Receive NIH Grant to Fund Antibiotic Trial for Patients with HIV and Emphysema

Dr. Robert KanerDr. Robert Kaner and Dr. Marshall Glesby are serving as co-Principal Investigators on an NIH-funded trial that is utilizing the antibiotic doxycyline for patients living with HIV and emphysema. In the amount of $7.8 million, the five-year grant is from the National Heart, Lung, and Blood Institute.The study is focused on whether doxycycline may slow the progression of the chronic lung disease, emphysema (a type of chronic obstructive pulmonary disease), in people with well-... Read More

Dr. Leonard Presents Key Finding at 2022 ASH Annual Meeting: Enhanced Progression-Free Survival in Patients with R/R Indolent non-Hodgkin’s Lymphoma

Dr. John LeonardDr. John Leonard presented key findings for the treatment of relapsed/refractory indolent non-Hodgkin’s lymphoma at the 2022 American Society of Hematology (ASH) Annual Meeting.Presenting results from a 5-year follow-up phase 3 AUGMENT trial, Dr. Leonard and colleagues found that rituximab (Rituxan) plus lenalidomide (Revlimid) elicited superior progression-free survival for patients with relapsed/refractory indolent non-Hodgkin’s lymphoma.The study involved 358 patients... Read More

Dr. Brandman Appointed as Medical Director for the Center for Liver Disease and Transplantation

Dr. Danielle BrandmanDanielle Brandman, M.D., M.A.S., has been appointed as the Medical Director for liver transplantation at Weill Cornell’s Center for Liver Disease and Transplantation (CLDT). The Center is run by Weill Cornell Medicine in partnership with NewYork-Presbyterian.Dr. Brandman was recruited to Weill Cornell from the University of California-San Francisco (UCSF) by Dr. Robert Brown to serve in this role following his promotion to Chief of Gastroenterology and Hepatology in the... Read More

WDOM Celebrates Dr. Johnson’s 60 Years of Distinguished Service in Infectious Diseases and Global Health

Dr. Warren D. Johnson, Jr.Former Division Chief of Infectious Diseases and founding Director of the Center for Global Health, Dr. Warren D. Johnson, Jr., is being celebrated on December 13, 2022, in honor of his 60 years of distinguished service as a physician, investigator, scholar, educator, and pioneer on the world stage.Dr. Johnson’s many years of leadership are legendary. He has mentored faculty and investigators working on some of the most virulent infectious diseases that exist around... Read More

In Recognition of National COPD Awareness Month the WDOM Highlights Dr. Martinez and the Division of Pulmonary and Critical Care Medicine

As November is National COPD Awareness Month, the WDOM recognizes the seminal work of Dr. Martinez and the faculty of the Division of Pulmonary and Critical Care Medicine.The National Institutes of Health notes that National COPD Awareness Month is a time to unite the COPD (chronic obstructive pulmonary disease) community in an effort to help patients, family caregivers and healthcare providers in order to find better treatments and/or a cure for COPD. COPD is the third leading cause of death... Read More

Dr. Prigerson Wins $7 Million Outstanding Investigator Award from the National Cancer Institute

Dr. Holly PrigersonFeatured in CRAIN's New York Business, Dr. Holly Prigerson has received a $7 Million Outstanding Investigator Award from the National Cancer Institute that will further her study of the psychosocial influences on care for dying cancer patients.A seven year renewal grant, this award will further research that Dr. Prigerson has been working on since 2015 focused on aggressive end-of-life care. In particular, Dr. Prigerson and her team will be piloting several interventions... Read More

Dr. Y. Michael Shim Named Chief of the Division of Pulmonary and Critical Care Medicine

Dr. Y. Michael Shim, an esteemed physician-scientist who specializes in advanced pulmonary imaging and obstructive airway diseases, was named chief of the Division of Pulmonary and Critical Care Medicine effective April 1.The division provides expert, comprehensive care for patients in the intensive care unit and for a range of pulmonary- and critical care-related conditions including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease and lung infections. The... Read More

Discovery Illuminates How Inflammatory Bowel Disease Promotes Colorectal Cancer

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with IBD have a higher risk of colorectal cancer, according to a preclinical study led by senior author Dr. Randy Longman. Read More

Hospitalists Leading the Way in Discharge Management

From left to right: Drs. Kirsten Homma, Sydney Katz, Laura Greisman and Samara LevinDrs. Kirsten Homma, Sydney Katz, Laura Greisman and Samara Levin presented at the Association of American Medical Colleges (AAMC) 2026 Northeast Group on Educational Affairs, representing Weill Cornell Medicine. Their presentation on “Overseeing the Last Mile: Supervising Discharge Management Using the SAFE‑DC Tool,” introduced a structured approach to improving trainee supervision during discharge planning and... Read More